Jamieson Bondarenko - 01 Aug 2022 Form 3 Insider Report for BriaCell Therapeutics Corp. (BCTX)

Role
Director
Signature
/s/ Jamieson Bondarenko
Issuer symbol
BCTX
Transactions as of
01 Aug 2022
Net transactions value
$0
Form type
3
Filing time
11 Aug 2022, 17:42:42 UTC
Next filing
20 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BCTX Common Shares 119,856 01 Aug 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BCTX Option (Right to Buy) 01 Aug 2022 Common Shares 150,000 $4.24 Direct
holding BCTX Option (Right to Buy) 01 Aug 2022 Common Shares 250,000 $8.47 Direct F1
holding BCTX Warrant 01 Aug 2022 Common Shares 30,000 $5.31 Direct
holding BCTX Warrant 01 Aug 2022 Common Shares 70,000 $5.31 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option vests quarterly for 2 years from the date of grant.